1. Home
  2. CHRD vs ALKS Comparison

CHRD vs ALKS Comparison

Compare CHRD & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chord Energy Corporation

CHRD

Chord Energy Corporation

HOLD

Current Price

$132.20

Market Cap

8.2B

Sector

Energy

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$51.11

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHRD
ALKS
Founded
2007
1987
Country
United States
Ireland
Employees
676
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.7B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
CHRD
ALKS
Price
$132.20
$51.11
Analyst Decision
Buy
Buy
Analyst Count
13
14
Target Price
$149.17
$43.43
AVG Volume (30 Days)
776.5K
1.7M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
3.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,475,899,000.00
Revenue This Year
$12.56
$24.26
Revenue Next Year
N/A
$4.47
P/E Ratio
$34.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.25
$25.17
52 Week High
$151.95
$55.67

Technical Indicators

Market Signals
Indicator
CHRD
ALKS
Relative Strength Index (RSI) 54.51 51.02
Support Level $86.73 $50.49
Resistance Level $141.72 $55.67
Average True Range (ATR) 3.49 1.68
MACD 1.69 -0.55
Stochastic Oscillator 57.92 30.88

Price Performance

Historical Comparison
CHRD
ALKS

About CHRD Chord Energy Corporation

Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: